RE-AIM THERAPEUTICS LTD

Active Oxford

Research and experimental development on biotechnology

1 employees website.com
Research and experimental development on biotechnology
R

RE-AIM THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 29 Apr 2024 Active Oxford, England 1 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 26 Jan 2026 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 5 May 2026 Next due 12 May 2027 12 months remaining
Net assets £-14K
Total assets £65K
Total Liabilities £79K
Charges None No charges registered

Contact & Details

Contact

Registered Address

Innovation Building Old Campus Road Roosevelt Drive Oxford OX3 7FZ England

Full company profile for RE-AIM THERAPEUTICS LTD (15689618), an active company based in Oxford, England. Incorporated 29 Apr 2024. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2025–2025)

Cash in Bank

£28.29k

Net Assets

-£14.06k

Total Liabilities

£78.66k

Turnover

N/A

Employees

1

Debt Ratio

122%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 229,284 Shares £7.35m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Oct 2025215,384£7.00m£32.5
28 Mar 20254,000£100k£25
23 Mar 20259,900£248k£25

Officers

Officers

3 active
Status
Fox, Justian CraigDirectorBritishEngland502 Oct 2025Active
Maroof, Asher, DrDirectorBritishUnited Kingdom4929 Apr 2024Active
Tsai, JohnDirectorAmericanSwitzerland582 Oct 2025Active

Shareholders

Shareholders (10)

Asher Maroof
79.0%
90,000
Jason Goldstein
8.8%
10,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Syncona Portfolio Limited

Unknown

Active
Notified 3 Oct 2025
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Asher Maroof

British

Active
Notified 29 Apr 2024
Residence United Kingdom
DOB September 1976
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

RE-AIM THERAPEUTICS LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 May 2026Confirmation StatementConfirmation statement made on 28 Apr 2026 with updates
13 Mar 2026OfficersChange to director Dr Asher Maroof on 2 Oct 2025
18 Feb 2026OfficersTermination of John Tsai as director on 18 Feb 2026
26 Jan 2026AccountsAnnual accounts made up to 30 Apr 2025
4 Nov 2025Persons With Significant ControlSyncona Portfolio Limited notified as a person with significant control
5 May 2026 Confirmation Statement

Confirmation statement made on 28 Apr 2026 with updates

13 Mar 2026 Officers

Change to director Dr Asher Maroof on 2 Oct 2025

18 Feb 2026 Officers

Termination of John Tsai as director on 18 Feb 2026

26 Jan 2026 Accounts

Annual accounts made up to 30 Apr 2025

4 Nov 2025 Persons With Significant Control

Syncona Portfolio Limited notified as a person with significant control

Recent Activity

Latest Activity

Confirmation statement made on 28 Apr 2026 with updates

1 weeks ago on 5 May 2026

Change to director Dr Asher Maroof on 2 Oct 2025

2 months ago on 13 Mar 2026

Termination of John Tsai as director on 18 Feb 2026

2 months ago on 18 Feb 2026

Annual accounts made up to 30 Apr 2025

3 months ago on 26 Jan 2026

Syncona Portfolio Limited notified as a person with significant control

6 months ago on 4 Nov 2025